Philip J Stella Selected Research

Philip J Stella Research Topics

Disease

22	Neoplasms (Cancer) 01/2020 - 01/2002
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 10/2002
5	Breast Neoplasms (Breast Cancer) 02/2022 - 07/2003
5	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 11/2004
4	Disease Progression 01/2022 - 08/2014
4	Lung Neoplasms (Lung Cancer) 01/2021 - 07/2003
4	Adenocarcinoma 05/2008 - 01/2002
3	Pain (Aches) 01/2016 - 07/2002
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 12/2015
2	Fatigue 01/2020 - 12/2016
2	Hypertension (High Blood Pressure) 01/2020 - 12/2016
2	Diarrhea 01/2020 - 01/2016
2	Stomatitis 12/2016 - 05/2014
2	Pneumonia (Pneumonitis) 12/2016 - 09/2003
2	Constipation 01/2016 - 07/2002
2	Nausea 01/2016 - 05/2011
2	Fever (Fevers) 01/2016 - 01/2002
2	Anemia 12/2015 - 01/2011
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2014 - 06/2005
2	Head and Neck Neoplasms (Head and Neck Cancer) 05/2014 - 04/2007
2	Peripheral Nervous System Diseases (PNS Diseases) 11/2011 - 07/2002
2	Hot Flashes 05/2010 - 06/2006
2	Stomach Neoplasms (Stomach Cancer) 03/2010 - 01/2007
1	Amenorrhea 02/2022
1	Rectal Neoplasms (Rectal Cancer) 08/2021
1	Proteinuria 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2018
1	Glioblastoma (Glioblastoma Multiforme) 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Respiratory Insufficiency (Respiratory Failure) 12/2016
1	Carcinogenesis 12/2016
1	Dyspnea (Shortness of Breath) 01/2016
1	Vomiting 01/2016
1	Chills 01/2016
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016
1	Edema (Dropsy) 01/2016
1	Inflammation (Inflammations) 12/2015
1	Circulating Neoplastic Cells 11/2011

Drug/Important Bio-Agent (IBA)

5	Carboplatin (JM8)FDA LinkGeneric 08/2013 - 10/2003
4	Bevacizumab (Avastin)FDA Link 01/2022 - 02/2010
4	Docetaxel (Taxotere)FDA Link 01/2017 - 01/2002
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 01/2002
3	Gemcitabine FDA Link 12/2015 - 06/2007
3	Paclitaxel (Taxol)FDA LinkGeneric 05/2011 - 10/2003
3	Cisplatin (Platino)FDA LinkGeneric 06/2007 - 07/2002
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2022 - 01/2017
2	Epirubicin (Ellence)FDA LinkGeneric 02/2022 - 01/2017
2	Fluorouracil (Carac)FDA LinkGeneric 02/2022 - 11/2004
2	Cetuximab (Erbitux)FDA Link 01/2022 - 01/2021
2	Phosphotransferases (Kinase)IBA 10/2019 - 04/2010
2	PlatinumIBA 10/2019 - 08/2014
2	Trastuzumab (Herceptin)FDA Link 01/2017 - 04/2012
2	Capecitabine (Xeloda)FDA Link 12/2015 - 04/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022
1	Trinitrotoluene (TNT)IBA 08/2021
1	pembrolizumabIBA 08/2021
1	durvalumabIBA 01/2021
1	neratinibIBA 01/2021
1	Panitumumab (Vectibix)FDA Link 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Lipase (Acid Lipase)FDA Link 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA 10/2019
1	Phosphatidylinositol 4,5-Diphosphate (Phosphatidylinositol 4,5 Diphosphate)IBA 10/2019
1	Everolimus FDA Link 01/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	cabozantinibIBA 12/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2016
1	Tyrosine Kinase InhibitorsIBA 12/2016
1	ruxolitinibIBA 12/2015
1	Janus KinasesIBA 12/2015
1	C-Reactive ProteinIBA 12/2015
1	src-Family KinasesIBA 08/2014
1	Biomarkers (Surrogate Marker)IBA 08/2014
1	Formaldehyde (Formol)FDA Link 08/2014
1	ParaffinIBA 08/2014
1	saracatinibIBA 08/2014
1	Doxepin (Mareen)FDA LinkGeneric 05/2014
1	vandetanib (ZD6474)IBA 08/2013
1	cediranib (AZD2171)IBA 01/2013
1	ErbB Receptors (EGF Receptor)IBA 04/2012
1	Vinorelbine (Navelbine)FDA LinkGeneric 04/2012
1	Keratin-19 (Keratin 19)IBA 11/2011
1	Vitamin E FDA LinkGeneric 11/2011
1	Gefitinib (Iressa)FDA Link 05/2011
1	Pilocarpine (Ocusert)FDA LinkGeneric 05/2011
1	IronIBA 01/2011
1	HematinicsIBA 01/2011
1	Darbepoetin alfa (Aranesp)FDA Link 01/2011

Therapy/Procedure

16	Therapeutics 02/2022 - 03/2003
16	Drug Therapy (Chemotherapy) 02/2022 - 10/2002
7	Radiotherapy 01/2018 - 10/2002
3	Neoadjuvant Therapy 08/2021 - 01/2017
2	Combined Modality Therapy 06/2005 - 09/2003
1	Adjuvant Chemotherapy 01/2021
1	Salvage Therapy 01/2020
1	Catheters 01/2016